Frequently Asked Questions
The market is segmented based on Global Human Immunodeficiency Virus (HIV) Diagnosis Market, By Product Type (Consumables, Assay, Kits and Reagents, Other Consumables, Instruments, Software and Services), Test Type (Antibody Tests, CD4 Count, Viral Load, Early Infant and Viral Identification), Application (Diagnostic Laboratories, Hospitals, Blood Banks, Home Care Settings and Others) – Industry Trends and Forecast to 2030.
.
The Global Hiv Diagnosis Market size was valued at USD 2.86 USD Billion in 2022.
The Global Hiv Diagnosis Market is projected to grow at a CAGR of 10% during the forecast period of 2023 to 2030.
The major players operating in the market include Abbott, Bio-Rad Laboratories , QIAGEN, Bayer AG, OraSure Technologies , Sysmex Corporation, Meridian Bioscience, Biogate Laboratories , J. Mitra & Co. Pvt. Ltd, General Biologicals Corporation, BioGenex, F. Hoffmann-La Roche , Mylan N.V., Siemens Healthcare GmbH, Thermo Fisher Scientific , Ortho Clinical Diagnostics, Quest Diagnostics ,orporated, Abcam Plc,.
The market report covers data from the U.S., Canada and Mexico in North America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC), Saudi Arabia, U.A.E, South Africa, Egypt, Israel, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA), Brazil, Argentina and Rest of South America as part of South America.
